The impact of medication regimen factors on adherence to chronic treatment: a review of literature
暂无分享,去创建一个
[1] P. Masand. Tolerability and adherence issues in antidepressant therapy. , 2003, Clinical therapeutics.
[2] Antonio Addis,et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. , 2002, Clinical therapeutics.
[3] B. Gazzard,et al. Better maintained adherence on switching from twice‐daily to once‐daily therapy for HIV: a 24‐week randomized trial of treatment simplification using stavudine prolonged‐release capsules , 2005, HIV medicine.
[4] J. Mullen,et al. A Random-Assignment, Double-Blind, Clinical Trial of Once- vs Twice-Daily Administration of Quetiapine Fumarate in Patients with Schizophrenia or Schizoaffective Disorder: A Pilot Study , 2003, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[5] D. Roter,et al. Patient adherence to HIV medication regimens: a review of published and abstract reports. , 2002, Patient education and counseling.
[6] W. Marelich,et al. Barriers to antiretroviral adherence among HIV-infected adults. , 2000, AIDS patient care and STDs.
[7] S. De Geest,et al. Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.
[8] J. Tolson,et al. Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection , 2000, AIDS.
[9] C. Hinkin,et al. Medication adherence among HIV+ adults , 2002, Neurology.
[10] E. Yiannakopoulou,et al. Adherence to antihypertensive treatment: a critical factor for blood pressure control. , 2005 .
[11] Loren G. Miller,et al. A prospective study of predictors of adherence to combination antiretroviral medication , 2002, Journal of General Internal Medicine.
[12] A. d’Arminio Monforte,et al. Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity , 2003, Neurology.
[13] A. Kaplan,et al. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] J R Ickovics,et al. Adherence in AIDS clinical trials: a framework for clinical research and clinical care. , 1997, Journal of clinical epidemiology.
[15] Anke Richter,et al. The impact of reducing dose frequency on health outcomes. , 2003, Clinical therapeutics.
[16] A. Peterson,et al. Meta-analysis of trials of interventions to improve medication adherence. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[17] Gary Marks,et al. Efficacy of Interventions in Improving Highly Active Antiretroviral Therapy Adherence and HIV-1 RNA Viral Load: A Meta-Analytic Review of Randomized Controlled Trials , 2006, Journal of acquired immune deficiency syndromes.
[18] Richard H. Chapman,et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. , 2005 .
[19] E. V. van Ameijden,et al. DRUG USERS AND HIV-COMBINATION THERAPY (HAART): FACTORS WHICH IMPEDE OR FACILITATE ADHERENCE , 2002, Substance use & misuse.
[20] E. Funkhouser,et al. Patient-perceived barriers to antiretroviral adherence: Associations with race , 2002, AIDS care.
[21] J. Berlin,et al. Patient misunderstanding of dosing instructions , 1996, Journal of General Internal Medicine.
[22] Susan Swindells,et al. Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection , 2000, Annals of Internal Medicine.
[23] S. Adlis,et al. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. , 1994, Archives of internal medicine.
[24] D. Spiegelman,et al. Patterns of Adherence With Antiretroviral Medications: An Examination of Between‐Medication Differences , 2001, Journal of acquired immune deficiency syndromes.
[25] Keith C. Norris,et al. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. , 1996, American journal of hypertension.
[26] Johnson George,et al. Development and Validation of the Medication Regimen Complexity Index , 2004, The Annals of pharmacotherapy.
[27] S. Calabrese,et al. The Antiretroviral Regimen Complexity Index: A Novel Method of Quantifying Regimen Complexity , 2007, Journal of acquired immune deficiency syndromes.
[28] B. Pinter. Continuation and compliance of contraceptive use , 2002, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[29] H. Mcdonald,et al. Interventions to enhance patient adherence to medication prescriptions: scientific review. , 2002, JAMA.
[30] M. Purucker,et al. Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day. , 2003, Chest.
[31] D. Apter,et al. Efficacy, Cycle Control, and User Acceptability of a Novel Combined Contraceptive Vaginal Ring , 2002, Obstetrics and gynecology.
[32] O. Ganda,et al. Migration and its impact on adiposity and type 2 diabetes. , 2007, Nutrition.
[33] P. Kardas,et al. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes) , 2005, Diabetes, obesity & metabolism.
[34] V. Stone,et al. Antiretroviral Regimen Complexity, Self‐Reported Adherence, and HIV Patients' Understanding of Their Regimens: Survey of Women in the HER Study , 2001, Journal of acquired immune deficiency syndromes.
[35] Thomas E. Freese,et al. Patient Characteristics, HIV Serostatus, and Risk Behaviors Among Gay and Bisexual Males Seeking Treatment for Methamphetamine Abuse and Dependence in Los Angeles , 2001, Journal of addictive diseases.
[36] L. Gerald,et al. Design of the supervised asthma therapy study: implementing an adherence intervention in urban elementary schools. , 2008, Contemporary clinical trials.
[37] C. J. McGrath,et al. Effect of exchange rate return on volatility spill-over across trading regions , 2012 .
[38] F. Brun-Vézinet,et al. Adherence to Antiretroviral Therapy and Outcomes in HIV-Infected Patients Enrolled in An Induction/Maintenance Randomized Trial , 2001, Antiviral therapy.
[39] Nicholas F Taylor,et al. …But Watch Out for the Weather: FACTORS AFFECTING ADHERENCE TO PROGRESSIVE RESISTANCE EXERCISE FOR PERSONS WITH COPD , 2007, Journal of cardiopulmonary rehabilitation and prevention.
[40] J. George,et al. Predictors of refill non-adherence in patients with heart failure. , 2007, British journal of clinical pharmacology.
[41] J. Morley,et al. Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial , 2003, Palliative medicine.
[42] C Inch,et al. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. , 2006, The Cochrane database of systematic reviews.
[43] A. Fisher,et al. Transdermal contraception: evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study. , 2002, American journal of obstetrics and gynecology.
[44] J. Stoner,et al. Patterns of adherence to antiretroviral medications: the value of electronic monitoring , 2003, AIDS.
[45] C. Nemeroff,et al. Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression. , 2002, The Journal of clinical psychiatry.
[46] G. Tataronis,et al. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. , 1999, Archives of internal medicine.
[47] R. Goldberg,et al. Discrepancies in the use of medications: their extent and predictors in an outpatient practice. , 2000, Archives of internal medicine.
[48] R Brian Haynes,et al. Helping patients follow prescribed treatment: clinical applications. , 2002, JAMA.
[49] S. Caillat-Zucman,et al. Prospective screening for human leukocyte antigen-B*5701 avoids abacavir hypersensitivity reaction in the ethnically mixed French HIV population. , 2007, Journal of acquired immune deficiency syndromes.
[50] S. Sereika,et al. Medication Adherence in Persons With Cardiovascular Disease , 2003, The Journal of cardiovascular nursing.
[51] Ryan O'Donnell,et al. Beyond compliance. , 2007, Occupational health & safety.
[52] A. Paes,et al. Impact of Dosage Frequency on Patient Compliance , 1997, Diabetes Care.
[53] A. Molassiotis,et al. A pilot study of the effects of a behavioural intervention on treatment adherence in HIV-infected patients , 2003, AIDS care.
[54] D. Nevedal,et al. What is a missed dose? Implications for construct validity and patient adherence , 2007, AIDS care.
[55] J. Parsons,et al. Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men , 2003, AIDS care.
[56] R. Kubacka,et al. Attitudes of patients with hypertension or arthritis toward the frequency of medication administration. , 1985, American journal of hospital pharmacy.
[57] R S Woodward,et al. The effect of prescribed daily dose frequency on patient medication compliance. , 1990, Archives of internal medicine.
[58] N. Hagen,et al. Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain , 1994, Cancer.
[59] Blair T. Johnson,et al. Efficacy of Antiretroviral Therapy Adherence Interventions: A Research Synthesis of Trials, 1996 to 2004 , 2006, Journal of acquired immune deficiency syndromes.
[60] S. Kane. Systematic review: adherence issues in the treatment of ulcerative colitis , 2006, Alimentary pharmacology & therapeutics.
[61] W. Bailey,et al. Medication adherence patterns in chronic obstructive pulmonary disease. , 1991, Chest.
[62] R. Lydiard. Irritable bowel syndrome, anxiety, and depression: what are the links? , 2001, The Journal of clinical psychiatry.
[63] P. Donnan,et al. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[64] A. Wu,et al. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[65] M. Tran,et al. Effects of Once-Daily and Twice-Daily Dosing on Adherence With Prescribed Glipizide Oral Therapy for Type 2 Diabetes , 2002, Southern medical journal.
[66] J. Cramer,et al. A systematic review of the associations between dose regimens and medication compliance. , 2001, Clinical therapeutics.
[67] A. Antinori,et al. Treatment‐Related Factors and Highly Active Antiretroviral Therapy Adherence , 2002, Journal of acquired immune deficiency syndromes.
[68] Brigitte L. Sicat. Ortho Evra, a New Contraceptive Patch , 2003, Pharmacotherapy.
[69] D. Singer,et al. Polypharmacy and medication adherence in patients with type 2 diabetes. , 2003, Diabetes care.
[70] R. Zuwallack,et al. A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. , 1992, Chest.